PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Azelaic Acid (Finacea Gel)- FDA 2 Drug Drug Doxycycline 9,324 1 0.01 -0.71 0.50 0.66
Dehydration 21,928 Disease Drug Droloxifene Citrate 2 1 0.00 -0.71 0.50 0.64
Drummondol 2 Drug Disease Leukemia 162,805 1 0.00 -0.71 0.50 0.60
Hyperthyroidism 16,816 Disease Disease Sever Condition 2 1 0.01 -0.71 0.50 0.65
Alocril (Nedocromil)- FDA 4 Drug Disease Asthma 109,610 2 0.00 -0.71 0.50 0.61
CD4 112,219 Target Target Ck-beta-11 4 2 0.00 -0.71 0.50 0.61
EPHB3 118 Target Target EPHB2 385 59 0.28 -0.65 0.50 0.88
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
Amphotericin B (Ambisome)- FDA 7 Drug Drug Abelcet (Amphotericin B Injection)- FDA 2 1 0.27 -0.65 0.50 0.90
Allergic Rhinitis 12,280 Disease Drug Azelastine hydrochloride (Optivar)- FDA 4 2 0.01 -0.71 0.50 0.66
Aricept (Donepezil Hydrochloride)- FDA 32 Drug Disease Dementia 66,782 16 0.01 -0.71 0.50 0.64
Menopause 19,680 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.01 -0.71 0.50 0.64
Acne 11,364 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.01 -0.71 0.50 0.65
Azelaic Acid Cream (Azelex)- FDA 2 Drug Disease Menopause 19,680 1 0.01 -0.71 0.50 0.64
Conjunctivitis 8,825 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.01 -0.71 0.50 0.66
Adalimumab (Humira)- FDA 62 Drug Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.09 -0.70 0.50 0.81
Aldara (Imiquimod)- FDA 36 Drug Disease Warts 5,574 18 0.04 -0.71 0.50 0.72
Carcinoma 433,099 Disease Disease Sever Condition 2 1 0.00 -0.71 0.50 0.58
Drummondol 2 Drug Disease Cancer 1,053,491 1 0.00 -0.71 0.50 0.56
Infectious Diseases 33,605 Disease Drug Dragonamide E 2 1 0.00 -0.71 0.50 0.63
Azelaic Acid (Finacea Gel)- FDA 2 Drug Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.50 -0.50 0.50 0.96
Ambisome (Amphotericin B)- FDA 7 Drug Drug Abelcet (Amphotericin B Injection)- FDA 2 1 0.27 -0.65 0.50 0.90
Infection 766,637 Disease Disease Hypertension (High Blood Pressure) 2 1 0.00 -0.71 0.50 0.57
Pneumonia 81,521 Disease Disease Hemorrhage Gastrointestinal 2 1 0.00 -0.71 0.50 0.61
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Infection 766,637 Disease Drug Doxycycline Calcium 2 1 0.00 -0.71 0.50 0.57
Abaperidone 2 Drug Disease Schizophrenia 77,034 1 0.00 -0.71 0.50 0.61
Aggression 20,035 Disease Drug Asenapine Sublingual Tablets (Saphris)- FDA 2 1 0.00 -0.71 0.50 0.64
Alli (Orlistat 60 mg)- FDA 2 Drug Disease Hepatitis 163,842 1 0.00 -0.71 0.50 0.60
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
Tuberculosis 146,217 Disease Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
Alli (Orlistat 60 mg)- FDA 2 Drug Disease Pain 409,851 1 0.00 -0.71 0.50 0.58
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Sever Condition 2 Disease Disease Pain 409,851 1 0.00 -0.71 0.50 0.58
Prostate Cancer 71,064 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 4 0.01 -0.71 0.50 0.63
CD4 112,219 Target Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
Chills 3,046 Disease Drug Abelcet (Amphotericin B Injection)- FDA 2 1 0.01 -0.71 0.50 0.69
Alli (Orlistat 60 mg)- FDA 2 Drug Disease Liver Disease 49,817 1 0.00 -0.71 0.50 0.62
Atromid-S (Clofibrate)- FDA 2 Drug Disease Hyperlipidemia 15,317 1 0.01 -0.71 0.50 0.65
Sever Condition 2 Disease Target Ret Proto-Oncogene 1,005 1 0.02 -0.71 0.50 0.72
Actemra (Tocilizumab Injection)- FDA 2 Drug Disease Inflammation 252,734 1 0.00 -0.71 0.50 0.59
Actemra (Tocilizumab Injection)- FDA 2 Drug Disease Pain 409,851 1 0.00 -0.71 0.50 0.58
Actemra (Tocilizumab Injection)- FDA 2 Drug Disease Hepatitis 163,842 1 0.00 -0.71 0.50 0.60
Influenza 67,933 Disease Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.61
Abilify (Aripiprazole)- FDA 71 Drug Drug Asenapine Sublingual Tablets (Saphris)- FDA 2 1 0.08 -0.70 0.50 0.81
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
Conjunctivitis 8,825 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.01 -0.71 0.50 0.66
Epilepsy 71,172 Disease Disease Hemorrhage Gastrointestinal 2 1 0.00 -0.71 0.50 0.61
Adp/Atp Translocase 3 2 Target Disease Breast Cancer 173,695 1 0.00 -0.71 0.50 0.60
Amphotericin B Injection (Abelcet)- FDA 2 Drug Drug Ambisome (Amphotericin B)- FDA 7 1 0.27 -0.65 0.50 0.90
Acne 11,364 Disease Drug Doxycycline Calcium 2 1 0.01 -0.71 0.50 0.65
Antizol (Fomepizole)- FDA 2 Drug Disease Seizures 66,465 1 0.00 -0.71 0.50 0.61
Dragmacidins 4 Drug Drug Dragmacidin D 4 2 0.50 -0.50 0.50 0.96
Dragomabin 2 Drug Disease Malaria 56,215 1 0.00 -0.71 0.50 0.62
Dragomabin 2 Drug Drug Dragonamide 5 1 0.32 -0.63 0.50 0.92
Dragonamide E 2 Drug Disease Malaria 56,215 1 0.00 -0.71 0.50 0.62
Amphotericin B Injection (Abelcet)- FDA 2 Drug Disease Chills 3,046 1 0.01 -0.71 0.50 0.69
Cancer 1,053,491 Disease Drug Drimenin 4 2 0.00 -0.71 0.50 0.56
Asenapine Sublingual Tablets (Saphris)- FDA 2 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.08 -0.70 0.50 0.81
Dragonamide E 2 Drug Disease Leishmaniasis 15,049 1 0.01 -0.71 0.50 0.65
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
Antizol (Fomepizole)- FDA 2 Drug Disease Coma 24,208 1 0.00 -0.71 0.50 0.64
Amphotericin B Injection (Abelcet)- FDA 2 Drug Drug Amphotericin B (Ambisome)- FDA 7 1 0.27 -0.65 0.50 0.90
Poisoning 53,779 Disease Drug Drofenine 2 1 0.00 -0.71 0.50 0.62
Amphotericin B Injection (Abelcet)- FDA 2 Drug Drug Doxorubicin 28,033 1 0.00 -0.71 0.50 0.63
Chagas Disease 8,212 Disease Drug Dragonamide E 2 1 0.01 -0.71 0.50 0.66
Arava (Leflunomide)- FDA 14 Drug Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.19 -0.68 0.50 0.87
Cancer 1,053,491 Disease Drug Aflibercept (Eylea)- FDA 14 7 0.00 -0.71 0.50 0.57
Adalimumab (Humira)- FDA 62 Drug Disease Arthritis 128,324 32 0.01 -0.70 0.52 0.63
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
CCL19 658 Target Target CCL21 808 344 0.47 -0.52 0.52 0.93
Cancer 1,053,491 Disease Target Aurora Kinase A 196 103 0.01 -0.69 0.53 0.59
Infection 766,637 Disease Target Tegument Protein Vp16 19 10 0.00 -0.69 0.53 0.58
Eotaxin-3/CCL26 26 Target Target Eotaxin-2/CCL24 19 10 0.45 -0.54 0.53 0.94
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Anxiety 113,510 Disease Disease Panic Attack 823 434 0.04 -0.69 0.53 0.68
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59
Non Small Cell Lung Cancer 28,563 Disease Drug Alimta (Pemetrexed)- FDA 28 15 0.02 -0.68 0.54 0.67
Alimta (Pemetrexed)- FDA 28 Drug Disease Mesothelioma 11,198 15 0.03 -0.68 0.54 0.70
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Cancer 1,053,491 21 0.00 -0.68 0.54 0.58
Panic Attack 823 Disease Disease Panic Disorder 7,455 444 0.18 -0.66 0.54 0.81
Seizure 44,685 Disease Disease Seizures 66,465 24,188 0.44 -0.54 0.54 0.88
Infection 766,637 Disease Disease Genital Herpes 2,660 1,442 0.03 -0.68 0.54 0.63
Acne 11,364 Disease Disease SAPHO Syndrome 378 205 0.10 -0.67 0.54 0.76
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
Epilepsy 71,172 Disease Disease Seizures Partial 11 6 0.01 -0.67 0.55 0.63
Epidermal Growth Factor Receptor 24,772 Target Disease Cancer 1,053,491 13,587 0.08 -0.67 0.55 0.66
Leukemias 14,152 Disease Disease Leukemia 162,805 7,764 0.16 -0.66 0.55 0.74
Sacroiliac Joint Pain 133 Disease Disease Back Pain 30,003 73 0.04 -0.67 0.55 0.69
Diabetes 332,602 Disease Disease Hyperglycemia 28,168 15,545 0.16 -0.65 0.55 0.73
Diabetes 332,602 Disease Disease Diabetic Nephropathy 12,496 6,932 0.11 -0.66 0.55 0.70
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL9 1,016 Target Target CXCL11 526 293 0.40 -0.56 0.56 0.91
CXCL3 145 Target Target CXCL2 750 81 0.25 -0.63 0.56 0.86
AKT2 873 Target Target AKT3 293 164 0.32 -0.60 0.56 0.88